The Natural Products Journal
Title:Meet Our Editorial Board Member
Volume: 5 Issue: 2
Author(s): William Cho
Affiliation:
Export Options
About this article
Cite this article as:
Cho William, Meet Our Editorial Board Member, The Natural Products Journal 2015; 5 (2) . https://dx.doi.org/10.2174/221031550502150702140450
DOI https://dx.doi.org/10.2174/221031550502150702140450 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Anti-Cancer Agents in Medicinal Chemistry Development of Radicicol Analogues
Current Cancer Drug Targets New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets The Study of Partial Microenvironment Pre- and Post-microwave Ablation in Rabbit Peripheral Pulmonary VX2 Tumors
Current Medical Imaging Mapping the High Throughput SEREX Technology Screening for Novel Tumor Antigens
Combinatorial Chemistry & High Throughput Screening Molecular Replacement in Cancer Therapy: Reversing Cancer Metabolic and Mitochondrial Dysfunction, Fatigue and the Adverse Effects of Cancer Therapy
Current Cancer Therapy Reviews In-silico Study to Identify Dietary Molecules as Potential SARS-CoV-2 Agents
Letters in Drug Design & Discovery Spinophilin: A New Tumor Suppressor at 17q21
Current Molecular Medicine Identifying Changes in the Synaptic Proteome of Cirrhotic Alcoholic Superior Frontal Gyrus
Current Neuropharmacology The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer
Current Drug Targets Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer Development
Current Cancer Drug Targets Novel Approaches to Modulate Apoptosis Resistance: Basic and Clinical Implications in the Treatment of Chronic Lymphocytic Leukemia (CLL)
Current Drug Delivery Retrospective Observational Study to Evaluate Causality, Preventability and Severity of Adverse Drug Reaction Associated with Anticancer Drugs in a Tertiary Care Hospital in Northern India
Current Drug Safety Bladder Cancer: Molecular Determinants of Personalized Therapy
Current Drug Targets Personalized Medicine for Glioblastoma: Current Challenges and Future Opportunities
Current Molecular Medicine Cyclophilin function in Cancer; lessons from virus replication
Current Molecular Pharmacology Gallium-68 in Medical Imaging
Current Radiopharmaceuticals Editorial [ Cardiovascular Risk Factor Modification: A sine qua non in the Management of Vascular Surgery Patients ]
Current Vascular Pharmacology New, Substituted Derivatives of Dicarboximides and their Cytotoxic Properties
Anti-Cancer Agents in Medicinal Chemistry Role of Tyrosine Kinase Inhibitors in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry